Gold(I)
complexes featuring Z-type ligands introducing electron-withdrawing
groups (EWG), Au(DPBF)Cl (4a) and Au(DPBCl)Cl (4b) (DPB = diphosphine-boron), have been
synthesized and structurally characterized. These studies suggest
that increasing the electron-withdrawing properties of the boron phenyl
substituent only results in minor structural changes of the gold complexes.
These complexes can be converted into Au(DPBF)SbF6 and Au(DPBCl)SbF6 by treatment of 4a,b with AgSbF6. The cationic complexes show
interesting catalytic properties and readily promote the cyclization
of yne-diols into unprecedented dioxabicyclo[3.2.2] derivatives.
The metal‐catalyzed carboxylation of propargylamines with aerial CO2 at room temperature to form 5‐methyleneoxazolidin‐2‐one derivatives has been developed. In this reaction, the catalyst [Au(dpbF)]X featuring a Z‐type ligand gave the best results, presumably due to the σ‐acceptance of the borane atom.
The synthesis of 2,2-dimethyloxepane frameworks based on the 7-endo-trig cyclization of ene-diol using a catalytic amount of metal catalysts (Au, Ag) or Brønsted acid (TfOH) has been developed. Also, the spirotype dioxabicyclic products were also derived from the diene-diols. For the condition using metal catalysts, the cyclization selectively reacted between the 1,1,3-trisubstituted alkenes and alcohols to form the 2,2-dimethyloxepane frameworks. On the other hand, the TfOH reacted with not only the 1,1,2-trisubstituted alkene, but also the 1-substituted and 1,2-disubstituted alkenes providing the corresponding cyclic ethers, which is quite different from the conditions of the metal catalysts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.